You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 22, December 10, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Transplantation immunology

A. M. VanBuskirk, D. J. Pidwell, P. W. Adams and C. G. Orosz

The practice of clinical and experimental transplantation continues to evolve at a rapid pace. To appreciate the current transplant practices, it is first necessary to review transplant immunology in its proper context, ie, as a component of the complex series of events that promote the repair of damaged tissues. These processes are generally categorized as inflammation, immunity, and tissue repair/reinforcement. In general, there are 3 forms of graft rejection: hyperacute, acute, and chronic rejection. All 3 forms of graft rejection represent pathologic consequences of one or more of these repair-related processes. The various graft rejection responses also illustrate several complex immunologic principles that need to be considered. These include the definition of an alloantigen, the structure and function of major histocompatibility complex molecules, and the behavior of antigen-presenting cells and alloreactive T cells. This review combines these concepts and principles into a discussion of the 3 forms of graft rejection, each of which is addressed at the level of histopathology, pathobiology, incidence, and clinical strategies.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Suppression of Acute and Chronic Rejection by Hepatocyte Growth Factor in a Murine Model of Cardiac Transplantation: Induction of Tolerance and Prevention of Cardiac Allograft Vasculopathy
Yamaura et al.
Circulation 2004;110:1650-1657.
ABSTRACT | FULL TEXT  

Indirect Minor Histocompatibility Antigen Presentation by Allograft Recipient Cells in the Draining Lymph Node Leads to the Activation and Clonal Expansion of CD4+ T Cells That Cause Obliterative Airways Disease
Richards et al.
J. Immunol. 2004;172:3469-3479.
ABSTRACT | FULL TEXT  

Identification of gene expression profile in tolerizing murine cardiac allograft by costimulatory blockade
Matsui et al.
Physiol. Genomics 2003;15:199-208.
ABSTRACT | FULL TEXT  

Retinal transplantation: progress and problems in clinical application
Lund et al.
J. Leukoc. Biol. 2003;74:151-160.
ABSTRACT | FULL TEXT  

Interleukin 15: biology and relevance to human disease
Fehniger and Caligiuri
Blood 2001;97:14-32.
FULL TEXT  

RANTES Plays an Important Role in the Evolution of Allograft Transplant-induced Fibrous Airway Obliteration
SUGA et al.
Am. J. Respir. Crit. Care Med. 2000;162:1940-1948.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.